Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
Condition(s):SchizophreniaLast Updated:July 7, 2021Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:July 7, 2021Completed
Condition(s):SchizophreniaLast Updated:April 29, 2014Completed
Condition(s):SchizophreniaLast Updated:January 5, 2022Completed
Condition(s):Schizophrenia; Mental IllnessLast Updated:August 29, 2019Unknown status
Condition(s):SchizophreniaLast Updated:December 16, 2021Completed
Condition(s):Schizophrenia; Schizoaffective DisordersLast Updated:February 28, 2014Completed
Condition(s):HealthyLast Updated:February 8, 2010Completed
Condition(s):HealthyLast Updated:February 8, 2010Completed
Condition(s):HealthyLast Updated:July 2, 2010Completed
Condition(s):HealthyLast Updated:July 2, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.